Cancer
Meet a nurse who leads clinical trials to find innovative cancer therapies
Melissa Martinez is a clinical scientist within Johnson & Johnson’s Interventional Oncology R&D group. Not only is she helping to develop lifesaving treatments, she’s redefining what it means to pursue a career in nursing.
5 things we now know about bladder cancer
Paradigm-shifting new therapies are helping people with the disease lead longer, more comfortable lives. Learn how Johnson & Johnson is helping to change the treatment landscape.
Could we be on our way to eliminating cancer for good?
What once seemed like an out-of-reach goal may soon be within our grasp. Learn how Johnson & Johnson is working toward its vision of helping create a world without cancer.
13 innovations that inspired us in 2023
A treatment for an incurable cancer. Catheters to better diagnose and treat AFib. A surgical stapler that’s easier to use. These are just some of the Johnson & Johnson advances that are helping improve the health of people everywhere.
By the numbers: Who gets lung cancer?
Each year, more people die of lung cancer than colon, breast and prostate cancers combined. Learn how Johnson & Johnson is dedicated to improving outcomes by integrating the company’s MedTech and Innovative Medicine expertise.
“So many people were there for me when I had cancer. Now I get to pay it forward”
As both a cancer survivor and caregiver, Shauna Smith knows the power of feeling supported when facing the disease. That’s why she founded Johnson & Johnson’s Cancer Focus Group—so every employee has somewhere to turn if they or someone they love is faced with a diagnosis.
How Johnson & Johnson is advancing new options for bladder cancer treatment
Every year, roughly 80,000 Americans receive a bladder cancer diagnosis. Many endure difficult and burdensome treatments in an attempt to fight the disease. But new innovations just might change that.
By the numbers: Helping to reduce disparities in cancer care
For World Health Day, learn how Johnson & Johnson’s commitment to Diversity, Equity and Inclusion is helping to deliver transformational cancer treatments and solutions that reach the patients who need them most.
These 6 women in STEM are on a mission to change the world
The Johnson & Johnson WiSTEM2D Scholars Award Program winners have big ideas—and an even bigger drive to inspire other women studying science, technology, engineering, math, manufacturing and design to pursue their dreams, too.
Could these 3 researchers transform the fates of patients with multiple myeloma?
For National Cancer Prevention Month, we’re spotlighting three leading Johnson & Johnson female hematologists—innovators who are not only saving lives and advancing new treatments but also paving the way for the next generation of women in their field.